Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System

Active Safety Monitoring of New Medical Products Using Electronic Healthcare Data

(2012) Joshua J. Gagne et al.   EPIDEMIOLOGY

Design considerations in an active medical product safety monitoring system

(2012) Joshua J. Gagne et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system

(2012) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

(2011) Jeremy A. Rassen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Commentary: What Can We Really Learn From Observational Studies?

(2011) David Madigan et al.   EPIDEMIOLOGY

Developing the Sentinel System — A National Resource for Evidence Development

(2011) Rachel E. Behrman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics

(2010) Jeremy A. Rassen et al.   MEDICAL CARE

Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins

(2010) Luis A. García Rodríguez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

(2010) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A basic study design for expedited safety signal evaluation based on electronic healthcare data

(2010) Sebastian Schneeweiss   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

(2009) Richard Platt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing Drug-Risk Information — What to Do with All Those New Numbers

(2009) Jerry Avorn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Hepatotoxicity Associated with the Use of Telithromycin: A Signal Detection Using Data Mining Algorithms

(2008) Yan Chen et al.   ANNALS OF PHARMACOTHERAPY

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

(2008) Allen D. Brinker et al.   HEPATOLOGY

The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases

(2008) Luis Alberto García-Rodríguez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care

(2008) Luis Alberto García-Rodríguez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY